The effort to grow the University at Buffalo and dramatically transform its three campuses has taken a major step forward with the awarding of a master planning contract to a team of internationally renowned architectural, planning, landscape and design firms.
Blood vessels that have been tissue-engineered from bone marrow adult stem cells may in the future serve as a patient's own source of new blood vessels following a coronary bypass or other procedures that require vessel replacement, according to new research from the University at Buffalo Department of Chemical and Biological Engineering.
A consortium of theoretical physicists co-founded by a University at Buffalo faculty member has been created to train more U.S. graduate students in theoretical high-energy particle physics calculations to counter "outsourcing" in their field that has allowed the U.S. to lag behind in this area of high-profile, global science.
A $500,000 gift from Ravinder K. Bansal, Ph.D., and his wife, Pratibha Bansal, M.D., of Clarence, to the University at Buffalo School of Engineering and Applied Sciences will be used for costs associated with the construction of a new engineering building on UB's North (Amherst) Campus.
Did God make scientists? Most of them don't think so. The first systematic analysis in decades to examine the religious beliefs and practices of elite academics in the sciences supports the notion that science professors at top universities are less religious than the general population, but attributes this to a number of variables that have little to do with their study of science.
A four-year study on iron metabolism within cells, an essential process that impacts both iron deficiency and iron toxicity, conditions responsible for a multitude of human diseases, is underway at the University at Buffalo funded by a $1.16 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
In a publication selected as a "2007 Hot Article" by the journal Biochemistry, University at Buffalo chemists report the discovery of a central mechanism responsible for the action of the powerful biological catalysts known as enzymes.
The University at Buffalo's Office of Science Technology Transfer and Economic Outreach (STOR) has announced that licensing and research agreements have been completed with Reichert, Inc., paving the way for developing and marketing a cell volume cytometer (CVC), whose applications include the detection of drug/cell interactions, bacterial sensitivity to antibiotics and cancer cell susceptibility to chemotherapeutic agents.
Martin K. Casstevens has been named business formation and commercialization manager for the Office of Science, Technology Transfer and Economic Outreach (STOR) at the University at Buffalo.
The UB Center for Advanced Biomedical and Bioengineering Technology (UB CAT) is funding University at Buffalo researchers working with 13 life sciences companies and organizations in Buffalo Niagara as part of $1 million in annual support provided by the New York State Foundation for Science, Technology and Innovation (NYSTAR) to the UB CAT.